Frank Glavin
Vice President and Head
Business Stratergy
Neovii
Switzerland
Biography
In this role, he oversees the group’s strategy, clinical and commercial development, and operations for North America. Mr Glavin brings over 15 years of drug and commercial development experience in both public and private companies to Neovii. Previously he was the Director of Therapeutics at CombinatoRx where he spearheaded translational drug development. Prior to that, Mr Glavin was part of the Serono Strategic Planning team and was a Life Science Management Consultant developing new-business incubation, in-licensing and acquisition, and franchise development strategies for global pharmaceutical and health care clients. Mr Glavin has a B.S. in Human Physiology from Boston University as well as an MBA from the Johnson Graduate School of Management at Cornell University.
Research Interest
Business Strategy, clinical and commercial development, and operations
